Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Robin who wrote (4429)	8/19/1998 12:39:00 PM
From: ralph keating	Respond to of 5736

The speed these guy's(SPRX) operate at put's this company to shame! The way in which no long will compare these two companies make me sleep better with my short... rk

To: Robin who wrote (4429)	8/19/1998 12:39:00 PM
From: Dixie7777	Read Replies (1) \| Respond to of 5736

Maybe you should come back when they get FDA approval. Or can ASSencio fix that? He'd better hope he can fix more than that in the coming *weeks.* And as I've said too many times before, only recently, we will have a deal. Better cover up, there's a chill wind blowing and you ain't gonna look too good in them shorts you're wearin.

To: Robin who wrote (4429)	8/19/1998 12:54:00 PM
From: Robin	Read Replies (1) \| Respond to of 5736

Also, looking at YOUR 10Q: << Note 2 -- Commitments and Contingencies: Business Risks -- The Company's business encompasses all of the risks inherent in the establishment of a new business enterprise, including a limited operating history with significant competition possessing substantially greater resources. >> Could this be SPRX??? << Operating Difficulties -- ... In the event the Colormate(TM) System units and related proprietary technology are not successfully leased/licensed and/or the products are not successfully marketed in the future, the principal effect may be a substantial write-down of the book value of such units. >> If and when the LED units are built (as the 800K expense suggests), these units are likely to be unmarketable and will most likely be expensed. << Management expects that the Company will have sufficient liquidity at least until July 1, 1999, even if no revenues from operations are generated and no additional financing is obtained. ... There can be no assurance that the Company will not require additional funding. If the Company has not been able to attract additional future financing or generate significant revenue from operations and/or successfully market its products and technologies, at such point in time, it may have to cease operations. >> Look carefully at this one! This is likely to be your future path! Unless the company successfully markets their Colormate (one year has passed and you're still waiting for the first morsel of progress), additional sources of capital will be required (more stock dilution with Reg S shares, I bet). If no additional capital can be obtained, then CCSI will have to declare bankruptcy, followed closely by delisting from the market (look at FPA Medical as a recent example). *** My advice should you intend to hang on to your miserably withering shares? Pray that some company absorbs CCSI quickly while some exchange rate can still be obtained. SPRX is quickly capturing the whole of the bilirubin market (and it does seem to be smaller than even SPRX had projected). Little if any market will be left for CCSI by the end of the year should Darby fail to produce by then (i.e., if she continues to be consistent in her level of performance)! As always, just my humble and unrespected opinion! More critiques on the 10Q to follow! Rockin' Robin